HST.977 Critical Reading and Technical Assessment of Biomedical Information
Gain experience in critical reading of scientific literature, including patents, journal articles and FDA labels, with an emphasis on analyzing clinical controversies and emerging technologies in subject areas that have been or could become sources of entrepreneurial activity. Students required to analyze a variety of topics in the scientific literature, including screening for and cost-effectiveness of early detection of cancer, therapeutic opportunities in oncology, evaluation of immunotoxins and antibody therapies, and new prospects for the treatment of autoimmune disorders. To support the discussion of these topics, outside experts may be invited to participate as facilitators.
This class has no prerequisites.
Lecture occurs 6:30 PM to 8:30 PM on Mondays in E25-101.
This class counts for a total of 3 credits.
In the Spring 2016 Half Term Subject Evaluations, HST.977 was rated 7.0 out of 7.0. You can find more information at the Health Sciences and Technology (HST) < MIT site or on the HST.977 Stellar site.
© Copyright 2015 Yasyf Mohamedali